Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Avallone

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|November 4, 2010
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylaseE Di Gennaro, G Piro, M I Chianese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancerF Caponigro, A Avallone, H McLeod, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial casesM Colombino, A Cossu, A Arba, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|January 28, 2006
Multidisciplinary approach to locally advanced rectal cancer: results of a single institution trialP Delrio, A Avallone, C Guida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinomaM Colombino, A Cossu, A Manca, et al.
International Journal of Cancer|June 17, 1999
Allelic loss on chromosome 6Q in primary prostate cancerV Srikantan, I A Sesterhenn, L Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trialP Comella, F De Vita, S Mancarella, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
Cancer Medicine|March 7, 2023
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trialsG Martini, D Ciardiello, V Famiglietti, et al.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|November 4, 2010
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylaseE Di Gennaro, G Piro, M I Chianese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancerF Caponigro, A Avallone, H McLeod, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial casesM Colombino, A Cossu, A Arba, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|January 28, 2006
Multidisciplinary approach to locally advanced rectal cancer: results of a single institution trialP Delrio, A Avallone, C Guida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinomaM Colombino, A Cossu, A Manca, et al.
International Journal of Cancer|June 17, 1999
Allelic loss on chromosome 6Q in primary prostate cancerV Srikantan, I A Sesterhenn, L Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trialP Comella, F De Vita, S Mancarella, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
Cancer Medicine|March 7, 2023
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trialsG Martini, D Ciardiello, V Famiglietti, et al.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
Pageof 7